The present invention relates to solid compositions, preferably in powder or granule form, based on minerals (semi-finished or raw material) and a process for preparing said solid compositions. Furthermore, the present invention relates to solid formulations (final products) and orally disintegrating formulations (final products) containing said solid compositions. Moreover, the present invention relates to a process for preparing said solid formulations and said orally disintegrating formulations. Finally, the present invention relates to the use of said solid compositions or said solid or orally disintegrating formulations in the treatment of disorders or diseases related to or derived from a deficiency of minerals such as magnesium (II), calcium (II), iron (III), zinc (II) and/or iodine. All the compositions or formulations of the present invention are suitable for pediatric subjects, adolescents, athletes, men, women, pregnant women and elderly.

Disclosed herein are polymorphic and amorphous forms of anhydrate, hydrate, and solvates of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide and methods of using such compositions for treating or suppressing oxidative stress disorders, including mitochondrial disorders, impaired energy processing disorders, neurodegenerative diseases and diseases of aging. Further disclosed are methods of making such polymorphic and amorphous forms.

A pet food composition specifically formulated for a small dog can include a combination of specific amino acids and probiotics to maintain or increase absorption of amino acids. Methods of increasing absorption of amino acids are also provided.

A pet food composition specifically formulated for a small dog can include a combination of specific amino acids and probiotics to maintain or increase absorption of amino acids. Methods of increasing absorption of amino acids are also provided.

The invention relates to a medical product for preventing or correcting vitamin A deficiency in a patient comprising a lipid emulsion in a flexible container, the lipid emulsion comprising (a) vitamin A in the lipid phase of the lipid emulsion, (b) optionally additionally vitamin D, vitamin E and/or vitamin K in the lipid phase of the lipid emulsion, and (c) no more than 1.5 ppm dissolved oxygen (DO), (d) wherein the pH of the lipid emulsion is from 5 to 9.

The present invention relates to the field of treating iron deficiency with IV iron carbohydrate complexes such ferric carboxymaltose, monitoring or identifying subjects to determine their eligibility for being administered said IV iron carbohydrate complexes, and combining said IV iron carbohydrate complexes with additional drugs in order to mitigate or reduce side effects induced by said IV iron carbohydrate complexes.

A method for improving health conditions is developed by studying the way meals containing adjusted nutritional components in terms of not only the content of the meal, but also time, period, and the like when the meals are taken. The present invention improves the health conditions by continually taking at least one meal selected from daily three meals, i.e., breakfast, lunch, and evening meal, which contains 13% to 20% of proteins, 20% to 30% of fats, and 50% to 65% of carbohydrates in terms of energy percentage and in which proteins, fats, carbohydrates, dietary fiber, vitamins, and minerals are adjusted to predetermined amounts.

A method for improving health conditions is developed by studying the way meals containing adjusted nutritional components in terms of not only the content of the meal, but also time, period, and the like when the meals are taken. The present invention improves the health conditions by continually taking at least one meal selected from daily three meals, i.e., breakfast, lunch, and evening meal, which contains 13% to 20% of proteins, 20% to 30% of fats, and 50% to 65% of carbohydrates in terms of energy percentage and in which proteins, fats, carbohydrates, dietary fiber, vitamins, and minerals are adjusted to predetermined amounts.

A compound represented by Formula (1) below or a salt thereof.

##STR00001##

Described in several example embodiments herein are formulations containing an amount of genistein optionally effective, in an avian, to modify the avian intestinal microbiome, increase a nutrient and/or mineral bioavailability and/or improve nutrient and/or mineral status in the avian, increase body weight gain, decrease feed conversion ratio, correct an iron deficiency, correct a Zn deficiency, support normal avian intestinal health and/or functionality and/or improve intestinal health and/or functionality, or any combination thereof and methods of the same.